Why the study?
Does prophylactic dextran 40 and venesection prevent deep vein thrombosis in patients with acute cerebral infarction and lower extremity paresis?
Does prophylactic dextran 40 and venesection prevent deep vein thrombosis in patients with acute cerebral infarction and lower extremity paresis?
Prophylactic dextran 40 and venesection did not significantly reduce the high incidence of deep vein thrombosis in patients with acute cerebral infarction and lower extremity paresis.
Does not support dextran 40 and venesection for DVT prophylaxis in acute stroke with paresis; confirms lack of benefit and directs research elsewhere.
In a prospective study of the incidence of deep vein thrombosis (DVT) after stroke, and the prophylactic effect of dextran, 50 patients, admitted with a diagnosis of cerebral infarction with paresis of the lower extremity within the first 48 hours, were randomly allocated to treatment or non-treatment groups. The treatment group received 500 ml of dextran 40 on admission and on days 1 and 2, and 250 ml on days 4 and 6. Venesection was performed on admission and if necessary on day 1. The control group received no dextran or venesection. DVT was diagnosed with the 125I-fibrinogen test during the first ten days. The incidence of DVT was 54% in the treatment group and 50% in the control group. There were no statistically significant differences between the groups regarding number of DVTs needing treatment, number of positive scanning points or number of days for scan to become positive. Lethal pulmonary emboli occurred in one treated and in three control patients, respectively. Age and progress of neurologic symptoms predisposed for the development of DVT. The high incidence of DVT in stroke patients indicates the need for prophylactic routines.
No takes yet. Share an insight, caveat, or question.
Mellbring et al. (1986) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: